• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示人类和鼠类 PD1 与其天然配体结合时 FG 环的保守构象。

Unraveling a Conserved Conformation of the FG Loop upon the Binding of Natural Ligands to the Human and Murine PD1.

机构信息

Molecular System Biology Department, Center of Molecular Immunology, Havana, Havana 11600, Cuba.

Center for Molecular Simulations, Biological Science Department, University of Calgary, Calgary, Alberta T2N 1N4, Canada.

出版信息

J Phys Chem B. 2022 Feb 24;126(7):1441-1446. doi: 10.1021/acs.jpcb.1c09463. Epub 2022 Feb 15.

DOI:10.1021/acs.jpcb.1c09463
PMID:35167293
Abstract

The activation of T cells is normally accompanied by inhibitory mechanisms within which the PD1 receptor stands out. PD1 drives T cells to an unresponsive state called exhaustion, characterized by a markedly decreased capacity to exert effector functions upon binding the ligands PDL1 and PDL2. For this reason, PD1 has become one of the most important targets in cancer immunotherapy. Despite the numerous studies about PD1 signaling modulation, how the PD1 signaling pathway is activated upon the ligands' binding remains an open question. In this work, we used molecular dynamics simulations to assess the differences of the PD1 motion in the free state and in complex with the ligands. We found that, in both human and murine systems, the binding of PDL1 and PDL2 stabilizes the conformation of the FG loop similarly. This result, combined with the conservation of the FG loop residues across species, suggests that the conformation of the FG loop is somehow related to the signaling process. We also found a high similarity between the PD1-PDL1 structures with the variable region of an antibody structure, where the FG loop occupies a similar position to the CDR3 light chain.

摘要

T 细胞的激活通常伴随着抑制机制,其中 PD1 受体尤为突出。PD1 使 T 细胞进入一种无反应状态,称为衰竭,其特征是在结合配体 PDL1 和 PDL2 时,效应功能的能力明显下降。出于这个原因,PD1 已成为癌症免疫疗法中最重要的靶点之一。尽管有许多关于 PD1 信号转导调节的研究,但配体结合后 PD1 信号通路如何被激活仍然是一个悬而未决的问题。在这项工作中,我们使用分子动力学模拟来评估 PD1 在游离状态和与配体结合时的运动差异。我们发现,在人和鼠系统中,PDL1 和 PDL2 的结合以相似的方式稳定 FG 环的构象。这一结果,加上 FG 环残基在物种间的保守性,表明 FG 环的构象与信号转导过程有关。我们还发现 PD1-PDL1 结构与抗体结构的可变区之间具有高度相似性,其中 FG 环占据与 CDR3 轻链相似的位置。

相似文献

1
Unraveling a Conserved Conformation of the FG Loop upon the Binding of Natural Ligands to the Human and Murine PD1.揭示人类和鼠类 PD1 与其天然配体结合时 FG 环的保守构象。
J Phys Chem B. 2022 Feb 24;126(7):1441-1446. doi: 10.1021/acs.jpcb.1c09463. Epub 2022 Feb 15.
2
Predicting a Stable Dimeric Form of the PD1-PDL1 Complex: Implications for Understanding the PD1 Activation Mechanism.预测 PD1-PDL1 复合物的稳定二聚体形式:对理解 PD1 激活机制的意义。
J Phys Chem B. 2023 Jul 6;127(26):5764-5771. doi: 10.1021/acs.jpcb.3c00911. Epub 2023 Jun 21.
3
Exploring the conformational dynamics of PD1 in complex with different ligands: What we can learn for designing novel PD1 signaling blockers?探讨 PD1 与其不同配体复合物的构象动力学:我们能从中学到什么来设计新型 PD1 信号阻断剂?
Proteins. 2021 Feb;89(2):141-148. doi: 10.1002/prot.26000. Epub 2020 Sep 11.
4
Recognition of PDL1/L2 by different induced-fit mechanisms of PD1: a comparative study of molecular dynamics simulations.PD1 不同诱导契合机制对 PDL1/L2 的识别:分子动力学模拟的比较研究。
Phys Chem Chem Phys. 2020 Jan 21;22(3):1276-1287. doi: 10.1039/c9cp05531b. Epub 2019 Dec 18.
5
Exploiting the Innate Plasticity of the Programmed Cell Death-1 (PD1) Receptor to Design Pembrolizumab H3 Loop Mimics.利用程序性细胞死亡受体 1(PD1)的固有可塑性来设计帕博利珠单抗 H3 环模拟物。
Chembiochem. 2022 Nov 4;23(21):e202200449. doi: 10.1002/cbic.202200449. Epub 2022 Sep 27.
6
Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform.Sym021,一种有前景的抗 PD1 临床候选抗体,源自一个新的鸡抗体发现平台。
MAbs. 2019 May/Jun;11(4):666-680. doi: 10.1080/19420862.2019.1596514. Epub 2019 May 3.
7
Using phage-assisted continuous evolution (PACE) to evolve human PD1.利用噬菌体辅助连续进化(PACE)技术来进化人源 PD1。
Exp Cell Res. 2020 Nov 1;396(1):112244. doi: 10.1016/j.yexcr.2020.112244. Epub 2020 Aug 27.
8
The PDL1-PD1 axis converts human TH1 cells into regulatory T cells.PD-L1-PD-1 轴将人类 TH1 细胞转化为调节性 T 细胞。
Sci Transl Med. 2011 Nov 30;3(111):111ra120. doi: 10.1126/scitranslmed.3003130.
9
Macrocyclic Compounds from Ansamycin Antibiotic Class as Inhibitors of PD1-PDL1 Protein-Protein Interaction.来自安莎霉素类抗生素的大环化合物作为PD1-PDL1蛋白质-蛋白质相互作用的抑制剂
Chem Pharm Bull (Tokyo). 2018;66(8):773-778. doi: 10.1248/cpb.c17-00800.
10
Nanobody against PDL1.抗 PDL1 纳米抗体。
Biotechnol Lett. 2020 May;42(5):727-736. doi: 10.1007/s10529-020-02823-2. Epub 2020 Jan 31.

引用本文的文献

1
A platform of ADAPTive scaffolds: development of CDR-H3 β-hairpin mimics into covalent inhibitors of the PD1/PDL1 immune checkpoint.适应性支架平台:将互补决定区-重链3β-发夹模拟物开发为程序性死亡蛋白1/程序性死亡配体1免疫检查点的共价抑制剂
RSC Chem Biol. 2024 Nov 4;5(12):1259-70. doi: 10.1039/d4cb00174e.
2
GNUV201, a novel human/mouse cross-reactive and low pH-selective anti-PD-1 monoclonal antibody for cancer immunotherapy.GNUV201,一种新型的人/鼠交叉反应性和低 pH 选择性抗 PD-1 单克隆抗体,用于癌症免疫治疗。
BMC Immunol. 2024 May 11;25(1):29. doi: 10.1186/s12865-024-00609-z.